Consistent with previous studies [19, 20], cells overexpressing XIAP had a reduction in NLRP3 signaling activation, and inflammation-associated dyslipidemia induced by PA treatment was eliminated in these cells (Figure 10A and 10B). The gene discussed is NLRP3; the disease is metabolic syndrome.